Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0091-3057(02)00849-3PMID 12117597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat.

  2001cited by this paper
• Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).

  2001cited by this paper
• Glutamate Receptors and Nociception

  2001cited by this paper
• Antinociceptive effect of a group II metabotropic glutamate receptor antagonist in the thalamus of monoarthritic rats.

  2000cited by this paper
• Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells.

  2000cited by this paper
• Expression of metabotropic glutamate receptors mRNA in the thalamus and brainstem of monoarthritic rats.

  2000cited by this paper
• Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.

  1999cited by this paper
• Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268

  1999cited by this paper
• Reduction of pain-related behaviors with either cold or heat treatment in an animal model of acute arthritis.

  1999cited by this paper
• Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

  1999cited by this paper
• [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.

  1999cited by this paper
• LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

  1998cited by this paper
• Inflammation alters the effects of mGlu receptor agonists on spinal nociceptive neurones.

  1998cited by this paper
• Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.

  1998cited by this paper
• 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.

  1998cited by this paper
• 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.

  1998cited by this paper
• In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonist.

  1997cited by this paper
• LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

  1997cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study.

  1997cited by this paper
• Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation.

  1997cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase.

  1996cited by this paper
• Distributions of the mRNAs for L‐2‐amino‐4‐phosphonobutyrate‐sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain

  1995cited by this paper
• The formalin test: scoring properties of the first and second phases of the pain response in rats

  1995cited by this paper
• The involvement of metabotropic glutamate receptors and their intracellular signalling pathways in sustained nociceptive transmission in rat dorsal horn neurons.

  1995cited by this paper
• Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.

  1995cited by this paper
• Metabotropic glutamate receptors: novel targets for drug development.

  1995cited by this paper
• Requirement of Metabotropic Glutamate Receptors for the Generation of Inflammation‐evoked Hyperexcitability in Rat Spinal Cord Neurons

  1994cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters.

  1994cited by this paper
• Novel functions for subtypes of metabotropic glutamate receptors.

  1994cited by this paper
• Intracellular Messengers Contributing to Persistent Nociception and Hyperalgesia Induced by L‐Glutamate and Substance P in the Rat Formalin Pain Model

  1994cited by this paper
• The formalin test: a validation of the weighted‐scores method of behavioural pain rating

  1993cited by this paper
• Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence

  1993cited by this paper
• Agonist analysis of 2‐(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells

  1992cited by this paper
• The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury

  1992cited by this paper
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

  1992cited by this paper
• The induction and maintenance of central sensitization is dependent on N‐methyl‐d‐aspartic acid receptor activation; implications for the treatment of post‐injury pain hypersensitivity states

  1991cited by this paper
• Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat.

  1990cited by this paper
• The rat paw formalin test: comparison of noxious agents

  1990cited by this paper
• Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection.

  1990cited by this paper
• Modified formalin test: characteristic biphasic pain response

  1989cited by this paper
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987cited by this paper
• Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat.

  1987cited by this paper
• Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation.

  1987cited by this paper
• Causalgia and other reflex sympathetic dystrophies.

  1973cited by this paper
• New tables for multiple comparisons with a control.

  1964cited by this paper
• THE MANAGEMENT OF PAIN

  1954cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper

• Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors.

  2025cites this paper
• Red nucleus mGluR2 but not mGluR3 mediates inhibitory effect in the development of SNI-induced neuropathological pain by suppressing the expressions of TNF-α and IL-1β.

  2024cites this paper
• Implication of system xc− in neuroinflammation during the onset and maintenance of neuropathic pain

  2024cites this paper
• The Mechanism and Inflammatory Markers Involved in the Potential Use of N-acetylcysteine in Chronic Pain Management

  2024cites this paper
• Presynaptic glutamate receptors in nociception.

  2023cites this paper
• Assessing the Effects of the Topical Application of L-Menthol on Pain-Related Somatosensory-Evoked Potentials Using Intra-Epidermal Stimulation

  2023cites this paper
• The distinctive role of menthol in pain and analgesia: Mechanisms, practices, and advances

  2022cites this paper
• Clinical investigations of compounds targeting metabotropic glutamate receptors.

  2022cites this paper
• Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors

  2022cites this paper
• Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases.

  2022cites this paper
• Emerging role of glutamate in the pathophysiology and therapeutics of Gulf War illness.

  2021cites this paper
• Fragment-Based Optimization of Dihydropyrazino-Benzimidazolones as Metabotropic Glutamate Receptor-2 Positive Allosteric Modulators against Migraine.

  2021cites this paper
• The inhibiting role of periaqueductal gray metabotropic glutamate receptor subtype 8 in a rat model of central neuropathic pain

  2020cites this paper
• Group II metabotropic glutamate receptor expressing neurons in anterior cingulate cortex become sensitized after inflammatory and neuropathic pain

  2020cites this paper
• Advances in the Treatment of Chronic Pain by Targeting GPCRs.

  2020cites this paper
• Acute Low Dose of Trazodone Recovers Glutamate Release Efficiency and mGlu2/3 Autoreceptor Impairments in the Spinal Cord of Rats Suffering From Chronic Sciatic Ligation

  2020cites this paper
• Acute spatial spread of NO‐mediated potentiation during hindpaw ischaemia in mice

  2019cites this paper
• Emerging Trends in Pain Modulation by Metabotropic Glutamate Receptors

  2019cites this paper
• Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.

  2019influential citation
• Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders

  2019influential citation
• Epigenetic Modulation of Visceral Pain

  2019cites this paper
• Synthesis and Pharmacological Characterization of C4β-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2794193), a Highly Potent and Selective mGlu3 Receptor Agon

  2018cites this paper
• Metabotropic Glutamate Receptor 2/3 (mGluR2/3) Activation Suppresses TRPV1 Sensitization in Mouse, But Not Human, Sensory Neurons

  2018cites this paper
• Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation

  2018cites this paper
• Effects of isovaline and involvement of metabotropic group ii glutamate receptors

  2018cites this paper
• Nociception modulation by supraspinal group III metabotropic glutamate receptors

  2017cites this paper
• Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.

  2017cites this paper
• Comparative Effects of LY3020371, a Potent and Selective mGlu2/3 Receptor Antagonist, and Ketamine, a Non-Competitive NMDA Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists for the Treatment of Depression

  2017cites this paper
• Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models

  2017cites this paper
• Histone acetylation and histone deacetylation in neuropathic pain: An unresolved puzzle?

  2017cites this paper
• Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine‐associated neurotoxic, motor, cognitive, subjective, or abuse‐liability‐related effects

  2017cites this paper
• Early‐life adversity, epigenetics, and visceral hypersensitivity

  2017cites this paper
• In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu2/3 receptor antagonist☆

  2017cites this paper
• Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain

  2017cites this paper
• Histone hyperacetylation modulates spinal type II metabotropic glutamate receptor alleviating stress-induced visceral hypersensitivity in female rats

  2016cites this paper
• Spinal plasticity of the nociceptive system

  2016cites this paper
• Group II mGluRs suppress hyperexcitability in mouse and human nociceptors

  2016cites this paper
• Metabotropic Glutamate Receptors in Central Nervous System Diseases.

  2016cites this paper
• Modulation of Chronic Pain by Metabotropic Glutamate Receptors.

  2016cites this paper
• Short report Open Access

  2015cites this paper
• Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain struct

  2015cites this paper
• mGluRs head to toe in pain.

  2015cites this paper
• mGlu 2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu 2 / mGlu 3 receptor agonists

  2015cites this paper
• Spinal mechanisms underlying potentiation of hindpaw responses observed after transient hindpaw ischemia in mice

  2015cites this paper
• Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective

  2015cites this paper
• Red nucleus glutamate facilitates neuropathic allodynia induced by spared nerve injury through non‐NMDA and metabotropic glutamate receptors

  2015cites this paper
• Therapeutic potential of targeting glutamate receptors in Parkinson’s disease

  2014cites this paper
• HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors

  2014cites this paper
• Investigating the expression of metabotropic glutamate receptors in trigeminal ganglion neurons and satellite glial cells: implications for craniofacial pain

  2014cites this paper
• mGlu3 receptor and astrocytes: partners in neuroprotection.

  2013cites this paper
• Effects of metabotropic glutamate receptor ligands on male sexual behavior in rats.

  2013cites this paper
• Synthesis and pharmacological characterization of 4-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: identification of new potent and selective metabotropic glutamate 2/3 receptor agonists.

  2013cites this paper
• Decoding the role of epigenetics and genomics in pain management.

  2013cites this paper
• Regulation of the β-endorphin precursor proopiomelanocortin in lymphocytes in a rat model of inflammatory pain

  2013cites this paper
• The glutamatergic system as a target for neuropathic pain relief

  2013cites this paper
• The role of glutamate signaling in pain processes and its regulation by GCP II inhibition.

  2012cites this paper
• Activation of the supraspinal opioid systems after peripheral noxious conditioning and inhibition of histone deacetylases

  2012influential citation
• Therapeutic Potential of Metabotropic Glutamate Receptor Modulators

  2012cites this paper
• Roles of Glia, Immune Cells and the Thermo-TRP Channels, TRPV1, TRPA1 and TRPM8, in Pathological Pain

  2012cites this paper
• Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model

  2012cites this paper
• Metabotropic glutamate receptors and the control of chronic pain.

  2012cites this paper
• Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system

  2012cites this paper
• Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.

  2011cites this paper
• Functional Plasticity of Group II Metabotropic Glutamate Receptors in Regulating Spinal Excitatory and Inhibitory Synaptic Input in Neuropathic Pain

  2011cites this paper
• Initial Phase of Neuropathic Pain within a Few Hours after Nerve Injury in Mice

  2011influential citation
• Epigenetics in pain and analgesia: An imminent research field

  2011cites this paper
• Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

  2011cites this paper
• mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists

  2011cites this paper
• Metabotropic glutamate antagonists alone and in combination with morphine: comparison across two models of acute pain and a model of persistent, inflammatory pain

  2011influential citation
• Study of Novel Selective mGlu2 Agonist in the Temporo-Ammonic Input to CA1 Neurons Reveals Reduced mGlu2 Receptor Expression in a Wistar Substrain with an Anxiety-Like Phenotype

  2011cites this paper
• Metabotropic glutamate receptors (mGluRs) regulate noxious stimulus‐induced glutamate release in the spinal cord dorsal horn of rats with neuropathic and inflammatory pain

  2010cites this paper
• mGluR1 Negative Allosteric Modulators: An Alternative Metabotropic Approach for the Treatment of Schizophrenia

  2010cites this paper
• A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE)

  2010cites this paper
• Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain.

  2010cites this paper
• A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity.

  2010cites this paper
• Opioid antinociception and antihyperalgesia in combination with metabotropic glutamate receptor antagonism

  2010cites this paper
• Differential roles of peripheral metabotropic glutamate receptors in bee venom-induced nociception and inflammation in conscious rats.

  2010cites this paper
• Metabotropic receptors for glutamate and GABA in pain.

  2009cites this paper
• Group III metabotropic glutamate receptors (mGluRs) modulate transmission of gustatory inputs in the brain stem.

  2009cites this paper
• Antinociceptive synergistic effect of spinal mGluR2/3 antagonist and glial cells inhibitor on peripheral inflammation-induced mechanical hypersensitivity.

  2009cites this paper
• Biological activities

  2009cites this paper
• Reducing and eliminating neuropathic pain.

  2009cites this paper
• Epigenetic Modulation of mGlu2 Receptors by Histone Deacetylase Inhibitors in the Treatment of Inflammatory Pain

  2009cites this paper
• Modulate Transmission of Gustatory Inputs in the Brainstem

  2009cites this paper
• Contralateral high or a combination of high- and low-frequency transcutaneous electrical nerve stimulation reduces mechanical allodynia and alters dorsal horn neurotransmitter content in neuropathic rats.

  2009cites this paper
• Group II metabotropic glutamate receptor activation on peripheral nociceptors modulates TRPV1 function.

  2009cites this paper
• Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed Investigations with a Selective Allosteric Metabotropic Glutamate Receptor 1 Antago

  2008influential citation
• Low doses of cannabinoids enhance the antinociceptive effects of intracisternally administered mGluRs groups II and III agonists in formalin‐induced TMJ nociception in rats

  2008cites this paper
• Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain

  2008cites this paper
• Spinal Cord Mechanisms of Hyperalgesia and Allodynia

  2008cites this paper
• Metabotropic Glutamate Receptor Ligands as Novel Therapeutic Agents

  2008cites this paper
• Morphine: axon regeneration, neuroprotection, neurotoxicity, tolerance, and neuropathic pain.

  2008cites this paper
• Glutamate receptor ligands.

  2007cites this paper
• The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.

  2007influential citation
• Analgesia mediated by the TRPM8 cold receptor in neuropathic pain

  2007cites this paper
• Synthesis and metabotropic glutamate receptor activity of S-oxidized variants of (-)-4-amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: identification of potent, selective, and orally bioavailable agonists for mGlu2/3 receptors.

  2007cites this paper
• Acetyl-L-Carnitine in Neuropathic Pain

  2007cites this paper
• [New antiepileptic drugs and neuropathic pain. From molecular medicine to clinical practice].

  2007cites this paper
• Nuevos fármacos antiepilépticos y dolor neuropático. De la medicina molecular a la clínica

  2007cites this paper
• Transcutaneous electrical nerve stimulation for the management of neuropathic pain: the effects of frequency and electrode position on prevention of allodynia in a rat model of complex regional pain syndrome type II.

  2006cites this paper